$2.51
$-0.09 (-3.46%)
End-of-day quote: 04/24/2024
NasdaqGM:CVAC
CureVac N.V. Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $577.39 | $591.94 | 0.00% | 1 | $220.40B |
| DHR | Danaher | NYSE | Outperform | $250.41 | $260.33 | 0.00% | 4 | $187.44B |
| PFE | Pfizer | NYSE | Outperform | $26.27 | $32.87 | 0.00% | 6 | $147.23B |
| SAN | Sanofi | ENXTPA | Outperform | 87.70€ | 102.80€ | 0.00% | 9 | 108.49€B |
| GSK | GSK | LSE | Outperform | £16.36 | £17.30 | 0.00% | 12 | £65.34B |
| MRNA | Moderna | NasdaqGS | Outperform | $108.85 | $135.42 | 0.00% | 1 | $38.83B |
| BNTX | BioNTech | NasdaqGS | Outperform | $88.09 | $123.75 | 0.00% | 3 | $20.92B |
| 1548 | Genscript Biotech | SEHK | Buy | HK$10.84 | HK$3.96 | 0.00% | 0 | HK$22.17B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $30.75 | $34.00 | 0.00% | 2 | $2.40B |
